High Tide Stock Price, News & Analysis

High Tide Inc. (NASDAQ: HITI) announced the opening of three new Canna Cabana retail locations in North York, Etobicoke, and Fort McMurray. The expansion brings the company's total store count to 210 locations across Canada, with 89 in Alberta and 88 in Ontario.

The new stores will open between September 26-29, 2025, strategically positioned in high-traffic areas. High Tide is maintaining its growth strategy of opening 2-3 new locations monthly, funded entirely through internal profits without external capital. The company currently holds a 12% market share in Canada and has been recognized as one of Canada's Top Growing Companies for four consecutive years.

High Tide Inc. (NASDAQ: HITI) reported outstanding Q3 2025 financial results, achieving record performance across key metrics. The company posted record revenue of $149.7 million, up 14% year-over-year, and record Adjusted EBITDA of $10.6 million.

Notable achievements include positive free cash flow of $7.7 million (up 148% YoY), positive net income of $832,000, and strong same-store sales growth of 7.4%. The company's Canna Cabana retail network expanded to 207 stores and captured 12% market share across five provinces. High Tide also completed a strategic acquisition of a 51% stake in Remexian, establishing a presence in Germany's medical cannabis market.

The company's Cabana Club loyalty program grew to over 2.15 million members in Canada and 6.15 million globally. With an annualized revenue run rate of approximately $600 million, High Tide remains the highest revenue-generating cannabis company reporting in Canadian dollars.

["Record quarterly revenue of $149.7M, up 14% YoY and 9% sequentially","Record Adjusted EBITDA of $10.6M, marking 22nd consecutive positive quarter","Free cash flow increased 148% YoY to $7.7M","Same-store sales growth of 7.4%, highest in two years","Strategic expansion into German market through 51% acquisition of Remexian","Market share increased to 12% from 11% year-over-year","Strong loyalty program growth with 2.15M Canadian members, up 39% YoY","Impressive retail metrics with $1,735 sales per square foot"]

High Tide (NASDAQ:HITI), a leading cannabis retail enterprise, announced its executives will present at several upcoming investor conferences between September and November 2025. CEO Raj Grover highlighted the company's recent acquisition of a majority stake in Remexian, making it a significant player in Germany's medical cannabis market.

High Tide operates 207 Canna Cabana locations across Canada, holding a 12% market share. The company has been recognized among Canada's Top Growing Companies for four consecutive years and ranked first in the retail category on the Financial Times' Americas' Fastest Growing Companies list for 2023. The company aims to expand beyond 300 stores nationwide.

High Tide Inc. (Nasdaq: HITI) has completed the acquisition of a 51% stake in Remexian Pharma GmbH for an estimated €26.4 million, marking its strategic entry into Europe's largest federally regulated cannabis market. The transaction implies an enterprise value of €53.4 million, representing 3.64x annualized Adjusted EBITDA.

The purchase was satisfied through €7.65 million in cash, a €7.65 million loan at 7% annual interest, and 5,864,373 High Tide shares valued at €11.1 million. High Tide also secured a five-year Call Option to acquire the remaining 49% stake after 24 months, while Remexian's owners received a Put Option, both with specific valuation multiples and payment conditions.

High Tide Inc. (Nasdaq: HITI) announced the opening of two new Canna Cabana retail cannabis stores in Ontario. The first location at 3221 Appleby Line in Burlington will open on August 29, 2025, while the second at 1294 Fanshawe Park Road East in London will open on September 4, 2025. These openings will increase High Tide's total store count to 207 locations across Canada, with 86 stores in Ontario.

The Burlington location, anchored by a national hardware store, serves nearly 41,000 residents within a three-kilometer radius. The London store, positioned in a high-growth area with limited competition, reaches over 25,000 residents within a five-minute drive. The company is also preparing to close its Remexian acquisition in Germany, marking its expansion into international markets.

High Tide Inc. (NASDAQ: HITI) announced the expansion of its Canna Cabana retail network with two new locations in Saskatoon, Saskatchewan and Lasalle, Ontario. The Saskatoon store, which began operations on August 18, 2025, is strategically located at 415 Circle Drive East, while the Lasalle location at 2055 Sandwich Parkway West will open on August 25, 2025.

These openings increase High Tide's total store count to 205 Canna Cabana locations across Canada, with 13 in Saskatchewan and 84 in Ontario. The company continues to execute its expansion strategy, with CEO Raj Grover expressing confidence in reaching the higher end of their 2025 target range. High Tide also highlights potential growth opportunities through their German market entry and possible U.S. cannabis reform.

High Tide Inc. (NASDAQ: HITI) has released preliminary guidance for Q3 2025, projecting record-breaking performance. The company expects revenue between $147-150 million, representing 7-9% sequential and 12-14% year-over-year growth, surpassing analyst consensus of $146 million.

The cannabis retailer anticipates Adjusted EBITDA of $9.6-10.6 million, showing 19-31% sequential growth and up to 10% year-over-year increase, significantly above analyst expectations of $8.4 million. Same-store sales growth reached a two-year high of 7.4%. The company also highlighted its recent expansion into Germany through the acquisition of Remexian Pharma GmbH.

High Tide will release full Q3 2025 results on September 15, 2025, after market close, with a conference call scheduled for the following morning.

High Tide Inc. (NASDAQ: HITI) has signed a definitive agreement to acquire a 51% stake in Remexian Pharma GmbH for €27.2 million, marking its entry into Germany's medical cannabis market. Remexian, a leading pharmaceutical company near Berlin, generated €65 million in revenue in the last 12 months and sold 7 tonnes of cannabis flower in Q2 2025, representing 16% of Germany's total imports.

The transaction implies an enterprise value of €53.4 million, representing 3.64x Annualized Adjusted EBITDA. The purchase will be satisfied through 42% in High Tide shares, 29% in cash, and 29% via seller loans. High Tide also secured options to acquire the remaining stake in Remexian.

This strategic acquisition positions High Tide in Germany's rapidly growing medical cannabis market, where patient numbers have increased from 250,000 to nearly 900,000, with annual revenues approaching €1 billion. The deal is expected to add approximately C$100 million in topline revenue and significant EBITDA annually to High Tide's financials.

High Tide Inc. (Nasdaq: HITI) provided several corporate updates, including progress on a significant German medical cannabis transaction that is fully funded through a recent junior secured loan. The company announced the appointment of Sri Pavithra Priyalakshmi as VP of Digital and eCommerce, bringing 11 years of global experience.

High Tide filed a new final base shelf prospectus allowing them to offer up to C$100 million in securities over 25 months, replacing their expiring prospectus. The company emphasized its disciplined approach, noting they only used $4 million of their previous $100 million shelf in the past two years.

Additionally, the company retained IR Agency for investor relations services at a fee of USD $140,000 and will participate in Canaccord Genuity's 45th Annual Growth Conference.